Federal Register / Vol. 87, No. 34 / Friday, February 18, 2022 / Notices 9369 

• Note that additional grant programs 

may be added pending Fiscal Year 2022 

and future Fiscal Year appropriations. 

Additionally, all RCORP grant award 

recipients are supported by eight 

cooperative agreements: RCORPTechnical Assistance, which provides 

extensive technical assistance to award 

recipients; RCORP-Evaluation, which 

evaluates the impact of the RCORP 

initiative on rural communities; three 

RCORP-Behavioral Health Care 

Workforce Centers, which provide 

workforce training and education 

initiatives in the region served by the 

Northern Border Regional Commission; 

and three RCORP-Centers of Excellence, 

which disseminate best practices related 

to the treatment for and prevention of 

substance use disorders within rural 

communities. 

A 60-day notice published in the 

Federal Register, 86 FR 69655 

(December 8, 2021). There were no 

public comments. 

Need and Proposed Use of the 

Information: Due to the growth in the 

number of grant programs included in 

the RCORP initiative, as well as 

emerging SUD and other behavioral 

health trends in rural communities, 

HRSA is submitting a revised package 

that includes changes to existing RCORP 

performance measures as well as new 

performance measures that better 

demonstrate the impact of the initiative 

on rural communities and reduce 

burden on the grant recipients. 

For this program, performance 

measures were developed to provide 

data on each RCORP initiative and to 

enable HRSA to provide aggregate 

program data required by Congress 

under the Government Performance and 

Results Act of 1993. These measures 

cover the principal topic areas of 

interest to the Federal Office of Rural 

Health Policy, including: (a) Provision 

of, and referral to, rural behavioral 

health care services, including SUD 

prevention, treatment and recovery 

support services; (b) behavioral health 

care, including SUD prevention, 

treatment, and recovery, process and 

outcomes; (c) education of health care 

providers and community members; (d) 

emerging trends in rural behavioral 

health care needs and areas of concern; 

and (e) consortium strength and 

sustainability. All measures will speak 

to the Federal Office of Rural Health 

Policy’s progress toward meeting the 

goals set. 

Likely Respondents: The respondents 

will be the grant award recipients of the 

RCORP initiatives. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

The below burden estimate is 

significantly lower than the original 

package submitted in 2019 (2,750 total 

burden hours). This is likely due to the 

fact that (1) many of the grant recipients 

HRSA consulted to obtain the burden 

estimate for this ICR revision have been 

collecting and reporting RCORP 

performance measures since March 

2020 and have a better understanding of 

the burden required; (2) HRSA 

eliminated and/or streamlined some of 

the more burdensome prevalence and 

workforce measures; and (3) grant 

recipients of the RCORPPsychostimulant program will only 

report on an annual (vs. biannual) basis. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

(annually) 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Rural Communities Opioid Response Program-Implementation/Neonatal Abstinence Syndrome/MAT Expansion .. 290 2 580 1.24 719.20 

Rural Communities Opioid Response ProgramPsychostimulant Support .................................................. 15 1 15 1.30 19.50 

Total .............................................................................. 305 ........................ 595 ........................ 738.70 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–03499 Filed 2–17–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–TR– 

20–001: Ethical Issues in Translational 

Science Research (R01 Clinical Trial 

Optional). 

Date: March 15, 2022. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sara Louise Hargrave, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 


jspears on DSK121TN23PROD with NOTICES1
9370 Federal Register / Vol. 87, No. 34 / Friday, February 18, 2022 / Notices 

Health, 6701 Rockledge Drive, Room 3170, 

Bethesda, MD 20892, (301) 443–7193, 

hargravesl@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–21– 

155: R15 Research Enhancement Award 

(AREA & REAP) Applications. 

Date: March 16, 2022. 

Time: 1:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rass M. Shayiq, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

2359, shayiqr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

conflict: Mechanisms in Cell and 

Developmental Biology. 

Date: March 16, 2022. 

Time: 3:00 p.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jonathan Arias, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5170, 

MSC 7840, Bethesda, MD 20892, 301–435– 

2406, ariasj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Infectious Diseases, 

Immunology and HIV/AIDS Biological. 

Date: March 22–23, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sharon Isern, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 810J, 

Bethesda, MD 20892, (301) 594–8197, 

iserns2@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–NS– 

22–002: Advancing Equity in Pain 

Management. 

Date: March 22, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Randolph Christopher 

Capps, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 1009J, Bethesda, MD 20892, (301) 435– 

1042, cappsrac@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Surgical Sciences, Biomedical 

Imaging and Bioengineering. 

Date: March 22, 2022. 

Time: 12:00 p.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Weihua Luo, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5114, 

MSC 7854, Bethesda, MD 20892, 301–435– 

1170, luow@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Medical Imaging Investigations. 

Date: March 25, 2022. 

Time: 9:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Guo Feng Xu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, (301) 237– 

9870, xuguofen@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Interdisciplinary Molecular 

Sciences and Training Neuroimaging 

Technologies. 

Date: March 25, 2022. 

Time: 9:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mufeng Li, Ph.D., 

Scientific Review Officer, The Center for 

Scientific Review, The National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–435–5653, limuf@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–OD– 

21–004: Maximizing the Scientific Value of 

Existing Biospecimen Collections (R21). 

Date: March 25, 2022. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maria Dolores Arjona 

Mayor, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institute of Health, 6701 Rockledge Drive, 

Room 806D, Bethesda, MD 20892, (301) 86– 

5309, arjonamayorm2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Exploratory/Developmental Research, 

Clinical Trials Readiness, Phased Innovation, 

and Data Science in Down Syndrome for the 

INCLUDE Project. 

Date: March 25, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Natalia Komissarova, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5207, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1206, komissar@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: Topics in Environmental 

Toxicology. 

Date: March 25, 2022. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Aiping Zhao, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2188, 

MSC 7818, Bethesda, MD 20892–7818, (301) 

435–0682, zhaoa2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in physiological and 

toxicological mechanisms. 

Date: March 25, 2022. 

Time: 1:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jianxin Hu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2156, 

MSC 7818, Bethesda, MD 20892, (301) 827– 

4417, jianxinh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–RM– 

21–014: Limited Competition: Continued 

Development of the Gabriella Miller Kids 

First Pediatric Data Resource Center (U2C). 

Date: March 25, 2022. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joonil Seog, SCD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–402–9791, joonil.seog@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 14, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03541 Filed 2–17–22; 8:45 am] 

BILLING CODE 4140–01–P 


jspears on DSK121TN23PROD with NOTICES1